Fidelity International’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Fidelity International’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,263,000	Closed	-$154M	–	897
2022 Q3	$154M	Buy	+2,263,000	New	+$125M	0.2%	128

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fidelity International's GBT Position: Q4 2022 in Review

Fidelity International sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2,263,000 shares — an estimated $154M sold.

Fidelity International first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $154M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Fidelity International reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Fidelity International sold 2,263,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $154M.
Fidelity International first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Fidelity International's Global Blood Therapeutics, Inc. position peaked at $154M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Fidelity International's 13F filing for Q4 2022, filed 13 Feb 2023.